Advertisement
Screener

AKEBIA THERAPEUTICS, INC. (AKBA) Current Income Tax Expense (Benefit)

1.9 / 5 stars · 34/88 Roast Me

AKEBIA THERAPEUTICS, INC. Current Income Tax Expense (Benefit)

AKEBIA THERAPEUTICS, INC. (AKBA) reported Current Income Tax Expense (Benefit) of $1.62 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.

Financial Statements › Expense Statement › Income Tax

us-gaap:CurrentIncomeTaxExpenseBenefit · last filed 2026-02-26

  • AKEBIA THERAPEUTICS, INC. current income tax expense (benefit) for fiscal 2025 was $1.62M.
  • AKEBIA THERAPEUTICS, INC. current income tax expense (benefit) for fiscal 2024 was $0.00.
  • AKEBIA THERAPEUTICS, INC. current income tax expense (benefit) for fiscal 2023 was $0.00.
  • AKEBIA THERAPEUTICS, INC. current income tax expense (benefit) for fiscal 2022 was $0.00.
Period endCurrent Income Tax Expense (Benefit) 12 month
2025-12-31$1.62M
10-K · filed 2026-02-26
2024-12-31$0.00
10-K · filed 2026-02-26
2023-12-31$0.00
10-K · filed 2026-02-26
2022-12-31$0.00
10-K · filed 2024-03-14
2021-12-31$0.00
10-K/A · filed 2023-08-28
2020-12-31$0.00
10-K · filed 2022-03-01
2019-12-31$0.00
10-K · filed 2022-03-01
2018-12-31$127.00K
10-K · filed 2021-02-25
2017-12-31$0.00
10-K · filed 2020-03-12
2016-12-31$0.00
10-K · filed 2019-03-26
2015-12-31$0.00
10-K · filed 2018-03-12
2014-12-31$0.00
10-K · filed 2017-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Greenwich LifeSciences, Inc. (GLSI)United States$0.267B-15.02
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
MACROGENICS INC (MGNX)United States$0.242B-20.11
Mereo BioPharma Group plc (MREO)$0.269B-9.41
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33